Effector Therapeutics Inc (EFTR) - News Archive

The end of eFFECTOR Therapeutics: Oncology biotech winds down after mid-stage failIt s the end of an era - eFFECTOR Therapeutics era, to be exact. The oncology biotech has announced plans to wind down operations and lay...

eFFECTOR Therapeutics Announces Wind Down and Delisting from NasdaqeFFECTOR Therapeutics, a biotechnology company based in Solana Beach, California, has made the decision to terminate its employees and wind down its ope...

In a move to further its mission of developing innovative and targeted treatments for cancer, eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) recently announced a definitive agreement to secure $15 million through a register...

In recent news, eFFECTOR Therapeutics, a leading biopharmaceutical company, has announced positive interim data from its dose escalation and Phase 2 expansion cohorts of Zotatifin in ER+ metastatic breast cancer patient...